European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012)

European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012)
复制标题

DOI:
10.1007/s12529-012-9242-5
复制
发表时间:
2012-12-01
影响因子:
2.7
通讯作者:
Zannad, Faiez
Zannad, Faiez
中科院分区:
心理学4区
文献类型:
--
作者:
Perk, Joep;De Backer, Guy;Zannad, Faiez

文献摘要

被引文献

相似文献

动脉粥样硬化性心血管疾病 (CVD) 是一种终生潜伏发展的慢性疾病,通常在症状出现时已发展至晚期。尽管近几十年来许多欧洲国家的心血管疾病死亡率大幅下降,但它仍然是欧洲过早死亡的主要原因。据估计,目前所有 CVD 死亡率的 80% 以上发生在发展中国家。 CVD 导致大规模残疾:在未来几十年内,残疾调整生命年 (DALY) 预计将从 1990 年损失 8500 万美元的 DALY 上升到 2020 年全球损失 1.5 亿美元的 DALY,从而仍然是生产力损失的主要躯体原因。 1 CVD 与生活方式密切相关,尤其是吸烟、不健康的饮食习惯、缺乏身体活动和社会心理压力。 2 世界卫生组织 (WHO) 表示,通过适当改变生活方式,四分之三以上的 CVD 死亡是可以预防的。 CVD 预防仍然是普通民众、政治家和医护人员面临的一项重大挑战,它被定义为在公众和个人层面上采取的一系列协调行动,旨在根除、消除或最大限度地减少 CVD 及其相关残疾的影响。预防的基础植根于心血管流行病学和循证医学。 3
Atherosclerotic cardiovascular disease (CVD) is a chronic disorder developing insidiously throughout life and usually progressing to an advanced stage by the time symptoms occur. It remains the major cause of premature death in Europe, even though CVD mortality has fallen considerably over recent decades in many European countries. It is estimated that> 80% of all CVD mortality now occurs in developing countries.CVD causes mass disability: within the coming decades the disability-adjusted life years (DALYs) estimate is expected to rise from a loss of 85 million DALYs in 1990 to a loss of $150 million DALYs globally in 2020, thereby remaining the leading somatic cause of loss of productivity. 1 CVD is strongly connected to lifestyle, especially the use of tobacco, unhealthy diet habits, physical inactivity, and psychosocial stress. 2 The World Health Organization (WHO) has stated that over three-quarters of all CVD mortality may be prevented with adequate changes in lifestyle. CVD prevention, remaining a major challenge for the general population, politicians, and healthcare workers alike, is defined as a co-ordinated set of actions, at public and individual level, aimed at eradicating, eliminating, or minimizing the impact of CVDs and their related disability. The bases of prevention are rooted in cardiovascular epidemiology and evidencebased medicine. 3